Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Latest collections open to submissions

We are welcoming submissions to the following article collections.


Microbiome in the First 1000 Days of Life

Guest Edited by Souhaila Al Khodor
Open until 10 December 2025


Harnessing Innovative Machine Learning Techniques to Combat Drug Resistance in Solid Tumors

Guest Edited by Wendy Mao and Hao Zhang
Open until 28 November 2025


Regeneration and Remodeling after Brain Injury: Implications for Stem Cell Therapy

Guest Edited by Hailiang Tang and Francisco Silva
Open until 19 December 2025


Prevention and Early Diagnosis of Breast Cancer

Guest Edited by Monica Pernia Marin, Caren Greenstein, and Mary Salvatore
Open until 31 August 2025

Article Collections

Fibrosis and Cancer Intersection

This article collection aims to clarify the correlation between tissue fibrosis and cancer origination and progression. 

"Planeterranean" Diet: Globally Extending the Health Benefits of the Mediterranean Diet

This article collection focuses on the challenge of transferring the Mediterranean Diet key concept to non-Mediterranean areas within a “One Health” perspective.

Join the Editorial Board

We are recruiting new Associate Editors to join our international Editorial Board. Learn more about the role and how to apply here.

Meet the Editors

Get to know the Editors behind Journal of Translational Medicine! 

Articles

Featured Research: Injection of human umbilical cord mesenchymal stem cells exosomes for the treatment of knee osteoarthritis: from preclinical to clinical research

This research study highlights the promising use of exosomes derived from human umbilical cord mesenchymal stem cells (hUC-MSC-Exos) as a treatment for knee osteoarthritis. These nano-sized vesicles were shown to reduce inflammation, promote cartilage repair, and improve joint function in both animal models and human patients, offering a safe and effective regenerative therapy that targets the root causes of joint degeneration rather than just managing symptoms.

Featured Review: Fecal microbiota transplantation from patients into animals to establish human microbiota-associated animal models: a scoping review

In a recent scoping review, explores how fecal microbiota transplantation (FMT) from patients into animals is used to create human microbiota-associated (HMA) models, helping researchers investigate the gut microbiome’s role in non-infectious diseases. Analysing nearly 500 studies, the review found that conditions like inflammatory bowel disease, obesity, colorectal cancer, and depression were most commonly studied, with over 80% of experiments successfully replicating disease traits in animals. Despite the promise of these models in demonstrating causality, the review highlights a lack of standardized methods and reporting, calling for clearer guidelines to improve reproducibility and support future systematic reviews in this growing field.

Top trending articles


Check out the
most discussed articles from the previous month!

Journal of Translational Medicine has launched In Review, a new option that provides authors with on-demand information on the status of their manuscript, enables them to share their work with funders and their research community, and allows their colleagues to comment and collaborate - all whilst their manuscript is under review.

Read More

Read our blogs

Q&A: Dr Souhaila Al Khodor

In this Q&A, Dr Al Khodor discusses her career and research focus on women's and infants health, her efforts to contribute directly to achieving SDG3, and the Microbiome in the First 1000 Days of Life collection launch.

Fibrosis, Cancer, and SDG3

Read about how the article collection Fibrosis and Cancer Intersection contributes to achieving the Sustainable Development Goal 3: Good Health and Wellbeing goal.

Aims and scope

Journal of Translational Medicine is an open access journal publishing articles focusing on information derived from human experimentation so as to optimise the communication between basic and clinical science.

The journal covers all areas of translational medicine but also has several special sections:

Editor-in-Chief: Francesco Marincola, USA

Francesco (Franco) Marincola is the Chief Scientific Officer of Translational and Advanced Medicine (TAM) Biosciences, Nashville, TN.  Franco brings over 30 years of research and development experience in immunology, oncology and cell therapy.

Most recently, Franco served as Chief Scientific Officer at Sonata Therapeutics, Boston, Massachusetts. Before he was Senior Vice President and Global Head of Research at Kite Pharma where he led the research organization to identify novel therapies for hematologic malignancies and solid tumors. Prior to Kite, he was President and Chief Scientific Officer at Refuge Biotechnologies, where he developed research strategies for adoptive cell therapy products and led therapeutic programs based on nuclease deactivated CRISPR circuits. Prior to Refuge, Franco was Distinguished Research Fellow in Immune Oncology at AbbVie, and Chief Research Officer at Sidra Medical and Research Centre.

Before joining the biopharma industry, Franco spent more than two decades at the National Institutes of Health (NIH) and National Cancer Institute (NCI), as a tenured senior investigator in cancer immunotherapy and biomarker research and as Chief Infectious Disease and Immunogenetics Investigator at the NIH Clinical Center.

Franco is the former President of the Society for Immunotherapy of Cancer (SITC). He currently serves as Editor-in-Chief for multiple peer-reviewed publications, including Journal of Translational Medicine, and Immunotherapy, and is the author of more than 700 peer-reviewed publications. 

Franco is also a fiction writer and his collections can be found at: 
https://wordpress.com/home/authorfrancomarincola.wordpress.com.

Franco received his M.D. from the University of Milan, Italy and completed his residency and training in immunology at Stanford University, California.

Annual Journal Metrics

  • Citation Impact 
    Journal Impact Factor: 7.5 (2024)   
    5-year Journal Impact Factor: 7.0 (2024)    
    Source Normalized Impact per Paper (SNIP): 1.321 (2024)    
    SCImago Journal Rank (SJR): 1.997 (2024)

    Speed 
    Submission to first editorial decision (median days): 11
    Submission to acceptance (median days): 99

    Usage 2024
    Downloads: 7,617,512
    Altmetric mentions: 6,383